HK1083183A1 - Drug eluting coatings for medical implants - Google Patents
Drug eluting coatings for medical implantsInfo
- Publication number
- HK1083183A1 HK1083183A1 HK06103244.2A HK06103244A HK1083183A1 HK 1083183 A1 HK1083183 A1 HK 1083183A1 HK 06103244 A HK06103244 A HK 06103244A HK 1083183 A1 HK1083183 A1 HK 1083183A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- drug eluting
- biologically active
- therapeutic agents
- medical implants
- eluting coatings
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40593302P | 2002-08-26 | 2002-08-26 | |
US10/423,718 US7438925B2 (en) | 2002-08-26 | 2003-04-26 | Drug eluting coatings for medical implants |
PCT/US2003/026364 WO2004017892A2 (en) | 2002-08-26 | 2003-08-22 | Drug eluting coatings for medical implants |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1083183A1 true HK1083183A1 (en) | 2006-06-30 |
Family
ID=31891527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06103244.2A HK1083183A1 (en) | 2002-08-26 | 2006-03-14 | Drug eluting coatings for medical implants |
Country Status (8)
Country | Link |
---|---|
US (3) | US7438925B2 (de) |
EP (1) | EP1549276B1 (de) |
JP (1) | JP5452832B2 (de) |
CN (1) | CN1674853B (de) |
AT (1) | ATE536176T1 (de) |
AU (1) | AU2003258331A1 (de) |
HK (1) | HK1083183A1 (de) |
WO (1) | WO2004017892A2 (de) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7013182B1 (en) * | 2000-05-04 | 2006-03-14 | Cardiac Pacemakers, Inc. | Conductive polymer sheath on defibrillator shocking coils |
AU2004237574A1 (en) * | 2003-03-13 | 2004-11-18 | Nitromed, Inc. | Nitrosated and nitrosylated compounds, compositions and methods of use |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
US8021680B2 (en) * | 2003-05-02 | 2011-09-20 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
JP2006525855A (ja) * | 2003-05-23 | 2006-11-16 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 吻合接合装置 |
US20070243632A1 (en) * | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
WO2005007868A2 (en) | 2003-07-08 | 2005-01-27 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
EP1682196A2 (de) * | 2003-11-10 | 2006-07-26 | Angiotech International Ag | Medizinische implantate und anti-narben-mittel |
ITTO20040056A1 (it) * | 2004-02-05 | 2004-05-05 | Sorin Biomedica Cardio Spa | Stent per l'erogazione endoliminale di principi o agenti attivi |
US20050232965A1 (en) * | 2004-04-15 | 2005-10-20 | Robert Falotico | Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
US7563780B1 (en) * | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US20050287184A1 (en) * | 2004-06-29 | 2005-12-29 | Hossainy Syed F A | Drug-delivery stent formulations for restenosis and vulnerable plaque |
PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
CA2586927A1 (en) * | 2004-11-09 | 2006-05-18 | Angiotech Biocoatings Corp. | Antimicrobial needle coating for extended infusion |
US20070051531A1 (en) * | 2005-09-08 | 2007-03-08 | Harshad Borgaonkar | Drug eluting coatings for a medical lead and method therefor |
WO2007040557A1 (en) * | 2005-09-21 | 2007-04-12 | Surmodics, Inc. | Coatings and articles including natural biodegradable polysaccharides |
US20090222080A1 (en) * | 2005-11-08 | 2009-09-03 | Picarus Nv Sa | Medical stent provided with inhibitors of tumor necrosis factor-alpha |
CA2645324A1 (en) * | 2006-03-15 | 2007-09-27 | Surmodics, Inc. | Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof |
US7881808B2 (en) * | 2006-03-29 | 2011-02-01 | Cardiac Pacemakers, Inc. | Conductive polymeric coating with optional biobeneficial topcoat for a medical lead |
TWI396562B (zh) * | 2006-08-16 | 2013-05-21 | Biovention Holdings Ltd | 藥物釋放的調節方法、藥物輸送組合物及醫療裝置 |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414525B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414909B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20090281059A1 (en) * | 2007-02-21 | 2009-11-12 | Robert Falotico | Coating for a medical device having an anti-thrombotic conjugate |
US20080200421A1 (en) * | 2007-02-21 | 2008-08-21 | Zhao Jonathon Z | Coating for a medical device having an anti-thrombotic conjugate |
US8383156B2 (en) | 2007-04-30 | 2013-02-26 | Cordis Corporation | Coating for a medical device having an anti-thrombotic conjugate |
US8133553B2 (en) | 2007-06-18 | 2012-03-13 | Zimmer, Inc. | Process for forming a ceramic layer |
US8309521B2 (en) | 2007-06-19 | 2012-11-13 | Zimmer, Inc. | Spacer with a coating thereon for use with an implant device |
US20090018646A1 (en) * | 2007-07-10 | 2009-01-15 | Zhao Jonathon Z | Coating Employing an Anti-Thrombotic Conjugate |
US8608049B2 (en) | 2007-10-10 | 2013-12-17 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
US20090104240A1 (en) * | 2007-10-19 | 2009-04-23 | Abbott Cardiovascular Systems Inc. | Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases |
CA2709712C (en) | 2007-12-20 | 2016-05-10 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles having a low residual solvent volume |
US8940003B2 (en) | 2008-02-22 | 2015-01-27 | Covidien Lp | Methods and apparatus for flow restoration |
KR101104901B1 (ko) * | 2008-05-23 | 2012-01-12 | 김영곤 | 능동 약물 방출형 서모 로드의 제조방법 및 이에 의해제조된 서모 로드 |
WO2010024898A2 (en) | 2008-08-29 | 2010-03-04 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
JP5638003B2 (ja) | 2009-01-12 | 2014-12-10 | ユニバーシティ オブ マサチューセッツ ローウェル | ポリイソブチレン系ポリウレタン |
US9622481B2 (en) | 2009-01-23 | 2017-04-18 | Kane Biotech Inc. | Biofilm-removing antimicrobial compositions and uses thereof |
CA2750340C (en) | 2009-01-23 | 2017-09-19 | Kane Biotech Inc. | Biofilm-removing antimicrobial compositions and uses thereof |
US9028878B2 (en) | 2009-02-03 | 2015-05-12 | Microbion Corporation | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
CA2751386C (en) * | 2009-02-03 | 2018-03-06 | Microbion Corporation | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
US9408393B2 (en) | 2010-02-03 | 2016-08-09 | Microbion Corporation | Bismuth-thiols as antiseptics for agricultural, industrial and other uses |
US9333280B2 (en) | 2009-02-25 | 2016-05-10 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
US8545459B2 (en) * | 2009-02-25 | 2013-10-01 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
JP2012523438A (ja) | 2009-04-10 | 2012-10-04 | タフツ メディカル センター インコーポレイテッド | メタロプロテイナーゼ−1(mmp−1)によるpar−1活性化 |
US8802121B2 (en) * | 2009-06-02 | 2014-08-12 | Surmodics, Inc. | Silane-functionalized hydrophobic α(1→4)glucopyranose polymers and polymeric matrices for implantation or injection |
US8586731B2 (en) * | 2009-06-11 | 2013-11-19 | Surmodics, Inc. | Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation |
US8529934B2 (en) | 2009-08-21 | 2013-09-10 | Boston Scientific Scimed, Inc. | Crosslinkable polyisobutylene-based polymers and medical devices containing the same |
US8753708B2 (en) | 2009-09-02 | 2014-06-17 | Cardiac Pacemakers, Inc. | Solventless method for forming a coating on a medical electrical lead body |
US8374704B2 (en) | 2009-09-02 | 2013-02-12 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same |
US8644952B2 (en) | 2009-09-02 | 2014-02-04 | Cardiac Pacemakers, Inc. | Medical devices including polyisobutylene based polymers and derivatives thereof |
WO2011041517A1 (en) * | 2009-09-30 | 2011-04-07 | Surmodics, Inc. | Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
US8568760B2 (en) * | 2009-12-30 | 2013-10-29 | Surmodics, Inc. | Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof |
JPWO2011096402A1 (ja) * | 2010-02-03 | 2013-06-10 | 独立行政法人物質・材料研究機構 | 生体適合性器具 |
WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
JP6104232B2 (ja) | 2012-03-27 | 2017-03-29 | テルモ株式会社 | コーティング組成物および医療機器 |
US9220584B2 (en) | 2012-03-30 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a stent and locally administered adjunctive therapy |
MX351261B (es) | 2012-06-01 | 2017-10-06 | Surmodics Inc | Aparato y método para recubrir catéteres con globo. |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11090468B2 (en) | 2012-10-25 | 2021-08-17 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US9060923B2 (en) * | 2012-11-02 | 2015-06-23 | Abbott Cardiovascular Systems Inc. | Method of treating vascular disease in diabetic patients |
EP2922888B1 (de) | 2012-11-21 | 2021-08-18 | The University of Massachusetts | Hochfeste polyisobutylen-polyurethane |
WO2014163093A1 (ja) * | 2013-04-01 | 2014-10-09 | テルモ株式会社 | コーティング組成物および医療機器 |
EP2898920B1 (de) | 2014-01-24 | 2018-06-06 | Cook Medical Technologies LLC | Gelenkballonkatheter |
CN104524646A (zh) * | 2014-06-03 | 2015-04-22 | 东莞天天向上医疗科技有限公司 | 生物可降解药物洗脱支架及其制作方法 |
CN105105892B (zh) * | 2015-08-04 | 2017-03-29 | 北京康容源医疗器械有限公司 | 一种药物洗脱球囊 |
EP3592786B1 (de) | 2017-03-07 | 2023-05-10 | Cardiac Pacemakers, Inc. | Hydroboration/oxidation von allylterminiertem polyisobutylen |
CN110997746B (zh) | 2017-08-17 | 2021-12-28 | 心脏起搏器股份公司 | 用于增强的耐久性的光交联聚合物 |
CN109925536B (zh) * | 2017-12-15 | 2021-01-26 | 先健科技(深圳)有限公司 | 可吸收铁基植入式器械 |
WO2019143629A1 (en) | 2018-01-17 | 2019-07-25 | Cardiac Pacemakers, Inc. | End-capped polyisobutylene polyurethane |
BR112021001731A2 (pt) | 2018-07-31 | 2021-04-27 | Microbion Corporation | composições de bismuto-tiol e métodos de uso |
JP2021533194A (ja) | 2018-07-31 | 2021-12-02 | マイクロビオン コーポレーション | ビスマス・チオール組成物及び創傷を治療する方法 |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
CN115252901B (zh) * | 2021-04-30 | 2023-11-21 | 沛嘉医疗科技(苏州)有限公司 | 一种改性生物瓣膜材料的制备方法和改性生物瓣膜材料 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663288A (en) | 1969-09-04 | 1972-05-16 | American Cyanamid Co | Physiologically acceptible elastomeric article |
NL188622C (nl) * | 1981-12-15 | 1992-08-17 | Cordis Europ | Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film. |
SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
US4676975A (en) | 1984-12-07 | 1987-06-30 | Becton, Dickinson And Company | Thermoplastic polyurethane anticoagulant alloy coating |
US4871357A (en) * | 1986-01-21 | 1989-10-03 | Baxter International Inc. | Ionic heparin coating |
US5047020A (en) | 1987-09-14 | 1991-09-10 | Baxter International Inc. | Ionic heparin coating |
US5061738A (en) | 1988-04-18 | 1991-10-29 | Becton, Dickinson And Company | Blood compatible, lubricious article and composition and method therefor |
US5525348A (en) * | 1989-11-02 | 1996-06-11 | Sts Biopolymers, Inc. | Coating compositions comprising pharmaceutical agents |
WO1991017724A1 (en) | 1990-05-17 | 1991-11-28 | Harbor Medical Devices, Inc. | Medical device polymer |
US5112457A (en) | 1990-07-23 | 1992-05-12 | Case Western Reserve University | Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of biomedical implants |
US5455040A (en) | 1990-07-26 | 1995-10-03 | Case Western Reserve University | Anticoagulant plasma polymer-modified substrate |
US5102401A (en) * | 1990-08-22 | 1992-04-07 | Becton, Dickinson And Company | Expandable catheter having hydrophobic surface |
US5356433A (en) | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
SE470006B (sv) * | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
US5516781A (en) | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
CA2094858C (en) * | 1992-04-28 | 2004-06-15 | Robert D. Mitchell | Method of treating hyperproliferative vascular disease |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
DE4437502A1 (de) * | 1993-12-02 | 1995-06-08 | Basf Ag | Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen |
US6231600B1 (en) * | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
US6179817B1 (en) | 1995-02-22 | 2001-01-30 | Boston Scientific Corporation | Hybrid coating for medical devices |
US5702754A (en) * | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
US5496832A (en) | 1995-03-09 | 1996-03-05 | American Home Products Corporation | Method of treating cardiac inflammatory disease |
US6120536A (en) * | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
JPH10155898A (ja) * | 1996-11-26 | 1998-06-16 | Toyobo Co Ltd | 抗菌性付与抗血栓性材料 |
US5980972A (en) | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
DE69831938T2 (de) | 1997-02-20 | 2006-07-06 | Cook Inc., Bloomington | Beschichtetes, implantierbares medizinisches geräte |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US5879697A (en) | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
US5906997A (en) * | 1997-06-17 | 1999-05-25 | Fzio Med, Inc. | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions |
US6306166B1 (en) | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
DE69901927T2 (de) | 1998-04-27 | 2002-10-10 | Surmodics Inc | Bioaktive wirkstoffe freisetzende beschichtungen |
AU771367B2 (en) | 1998-08-20 | 2004-03-18 | Cook Medical Technologies Llc | Coated implantable medical device |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
JP2000202031A (ja) * | 1999-01-20 | 2000-07-25 | Nippon Sherwood Medical Industries Ltd | 抗凝血性イントロデュ―サ―シ―ス |
US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6309660B1 (en) | 1999-07-28 | 2001-10-30 | Edwards Lifesciences Corp. | Universal biocompatible coating platform for medical devices |
US6749626B1 (en) * | 2000-03-31 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Actinomycin D for the treatment of vascular disease |
US6251136B1 (en) | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
WO2001047572A2 (en) * | 1999-12-29 | 2001-07-05 | Advanced Cardiovascular Systems, Inc. | Device and active component for inhibiting formation of thrombus-inflammatory cell matrix |
JP4626005B2 (ja) * | 2000-01-27 | 2011-02-02 | 東洋紡績株式会社 | 血液適合性組成物およびそれを被覆した医療用具 |
JP5100951B2 (ja) * | 2000-09-29 | 2012-12-19 | コーディス・コーポレイション | 被覆医用器具 |
KR100378109B1 (ko) * | 2000-10-24 | 2003-03-29 | 주식회사 메디프렉스 | 소수성 다중복합 헤파린 결합체, 그의 제조방법 및 용도 |
US6854125B2 (en) * | 2000-11-07 | 2005-02-08 | Matshushita Electric Industrial Co., Ltd. | Magnetic head |
CN1360951A (zh) * | 2000-12-28 | 2002-07-31 | 微创医疗器械(上海)有限公司 | 一种具有防再狭窄涂层的血管支架 |
CN1492759A (zh) | 2001-01-16 | 2004-04-28 | Ѫ�������������ι�˾ | 预防或治疗血液透析中血管通路和其它血管移植物故障的装置及方法 |
US8101199B2 (en) * | 2003-10-21 | 2012-01-24 | Celonova Biosciences, Inc. | Des-methyl-tocopherol therapy for restenosis prevention |
-
2003
- 2003-04-26 US US10/423,718 patent/US7438925B2/en not_active Expired - Lifetime
- 2003-08-22 AU AU2003258331A patent/AU2003258331A1/en not_active Abandoned
- 2003-08-22 AT AT03793302T patent/ATE536176T1/de active
- 2003-08-22 EP EP03793302A patent/EP1549276B1/de not_active Expired - Lifetime
- 2003-08-22 JP JP2004529865A patent/JP5452832B2/ja not_active Expired - Fee Related
- 2003-08-22 WO PCT/US2003/026364 patent/WO2004017892A2/en active Application Filing
- 2003-08-22 CN CN038185466A patent/CN1674853B/zh not_active Expired - Lifetime
-
2005
- 2005-04-28 US US11/119,075 patent/US8357386B2/en active Active
-
2006
- 2006-03-14 HK HK06103244.2A patent/HK1083183A1/xx not_active IP Right Cessation
-
2008
- 2008-10-20 US US12/254,749 patent/US8753663B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US8357386B2 (en) | 2013-01-22 |
AU2003258331A8 (en) | 2004-03-11 |
EP1549276B1 (de) | 2011-12-07 |
EP1549276A2 (de) | 2005-07-06 |
JP2005536263A (ja) | 2005-12-02 |
US20050191333A1 (en) | 2005-09-01 |
EP1549276A4 (de) | 2006-10-25 |
WO2004017892A3 (en) | 2004-07-01 |
US7438925B2 (en) | 2008-10-21 |
US20040037886A1 (en) | 2004-02-26 |
US20090043388A1 (en) | 2009-02-12 |
JP5452832B2 (ja) | 2014-03-26 |
ATE536176T1 (de) | 2011-12-15 |
WO2004017892A2 (en) | 2004-03-04 |
CN1674853A (zh) | 2005-09-28 |
AU2003258331A1 (en) | 2004-03-11 |
CN1674853B (zh) | 2010-04-28 |
US8753663B2 (en) | 2014-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1083183A1 (en) | Drug eluting coatings for medical implants | |
ATE298592T1 (de) | Arzneimittelkombinationen zur restenose- prävention | |
ES2444792T3 (es) | Dispositivos médicos implantables o insertables | |
CN107043561B (zh) | 聚合物涂料组合物和涂覆的产品 | |
EP2255836A3 (de) | Medizinische Vorrichtungen mit Rapamycin-analoga | |
WO2007046935A3 (en) | Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices | |
WO2007111925A3 (en) | Zotarolimus-containing drug delivery systems for implantation into a body lumen of a subject | |
CA2529742A1 (en) | Composition of a vegf antagonist and an anti-proliferative agent | |
CA2502146A1 (en) | Solution formulations of sirolimus and its analogs for cad treatment | |
EP1753476A4 (de) | Vorläufer-endothelzell-erfassung mit einem arzneimittel abgebenden implantierbaren medizinprodukt | |
DE602005018178D1 (de) | Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen | |
WO2008045961A3 (en) | Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices | |
WO2002047731A3 (en) | Drug delivery compositions and coated medical devices | |
RU2008107255A (ru) | Системы введения лекарственных средств, содержащих рапамицин и его производные, которые предназначены для предупреждения и лечения сосудистых заболеваний | |
ATE313586T1 (de) | Mehrarmige blockcopolymere und pharmazeutische zusammensetzung | |
WO2010019721A3 (en) | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device | |
WO2007059253A3 (en) | Progenitor endothelial cell capturing with a drug eluting implantable medical device | |
WO2008021124A3 (en) | Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel | |
EP2291431A1 (de) | Biologisch abbaubare blockcopolymere für die kontrollierte wirkstofffreigabe | |
EP2042202A3 (de) | Lokale vaskuläre Abgabe von mTOR-Inhibitoren in Kombination mit von Peroxisom-Proliferatoren aktivierten Rezeptorstimulatoren | |
WO2007032777A3 (en) | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy | |
CA2569542A1 (en) | A delivery system | |
JP2008534074A5 (de) | ||
EP1792966A3 (de) | Polymerzusammensetzungen zur kontrollierten Wirkstofffreisetzung bzw. zum Transport von Wirkstoffen | |
ES2744848T3 (es) | Dispositivo médico de liberación de inhibidor de mTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220822 |